Literature DB >> 16987939

Engineering of cytochrome P450 3A4 for enhanced peroxide-mediated substrate oxidation using directed evolution and site-directed mutagenesis.

Santosh Kumar1, Hong Liu, James R Halpert.   

Abstract

CYP3A4 has been subjected to random and site-directed mutagenesis to enhance peroxide-supported metabolism of several substrates. Initially, a high-throughput screening method using whole cell suspensions was developed for H2O2-supported oxidation of 7-benzyloxyquinoline. Random mutagenesis by error-prone polymerase chain reaction and activity screening yielded several CYP3A4 mutants with enhanced activity. L216W and F228I showed a 3-fold decrease in Km, HOOH and a 2.5-fold increase in kcat/Km, HOOH compared with CYP3A4. Subsequently, T309V and T309A were created based on the observation that T309V in CYP2D6 has enhanced cumene hydroperoxide (CuOOH)-supported activity. T309V and T309A showed a > 6- and 5-fold higher kcat/Km, CuOOH than CYP3A4, respectively. Interestingly, L216W and F228I also exhibited, respectively, a > 4- and a > 3-fold higher kcat/Km, CuOOH than CYP3A4. Therefore, several multiple mutants were constructed from rationally designed and randomly isolated mutants; among them, F228I/T309A showed an 11-fold higher kcat/Km, CuOOH than CYP3A4. Addition of cytochrome b5, which is known to stimulate peroxide-supported activity, enhanced the kcat/Km, CuOOH of CYP3A4 by 4- to 7-fold. When the mutants were tested with other substrates, T309V and T433S showed enhanced kcat/Km, CuOOH with 7-benzyloxy-4-(trifluoromethyl)coumarin and testosterone, respectively, compared with CYP3A4. In addition, in the presence of cytochrome b5, T433S has the potential to produce milligram quantities of 6beta-hydroxytestosterone through peroxide-supported oxidation. In conclusion, a combination of random and site-directed mutagenesis approaches yielded CYP3A4 enzymes with enhanced peroxide-supported metabolism of several substrates.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16987939     DOI: 10.1124/dmd.106.012054

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  14 in total

1.  Effect of alcohol on drug efflux protein and drug metabolic enzymes in U937 macrophages.

Authors:  Mengyao Jin; Priyanka Arya; Kalpeshkumar Patel; Bhupendra Singh; Peter S Silverstein; Hari K Bhat; Anil Kumar; Santosh Kumar
Journal:  Alcohol Clin Exp Res       Date:  2010-10-06       Impact factor: 3.455

2.  Re-engineering cytochrome P450 2B11dH for enhanced metabolism of several substrates including the anti-cancer prodrugs cyclophosphamide and ifosfamide.

Authors:  Ling Sun; Chong S Chen; David J Waxman; Hong Liu; James R Halpert; Santosh Kumar
Journal:  Arch Biochem Biophys       Date:  2007-01-08       Impact factor: 4.013

Review 3.  Peroxygenase reactions catalyzed by cytochromes P450.

Authors:  Osami Shoji; Yoshihito Watanabe
Journal:  J Biol Inorg Chem       Date:  2014-02-06       Impact factor: 3.358

4.  Differential effects of ethanol on spectral binding and inhibition of cytochrome P450 3A4 with eight protease inhibitors antiretroviral drugs.

Authors:  Santosh Kumar; Anil Kumar
Journal:  Alcohol Clin Exp Res       Date:  2011-06-17       Impact factor: 3.455

5.  Dehydrogenation of the indoline-containing drug 4-chloro-N-(2-methyl-1-indolinyl)-3-sulfamoylbenzamide (indapamide) by CYP3A4: correlation with in silico predictions.

Authors:  Hao Sun; Chad Moore; Patrick M Dansette; Santosh Kumar; James R Halpert; Garold S Yost
Journal:  Drug Metab Dispos       Date:  2008-12-12       Impact factor: 3.922

6.  Ligand diversity of human and chimpanzee CYP3A4: activation of human CYP3A4 by lithocholic acid results from positive selection.

Authors:  Santosh Kumar; Huan Qiu; Numan Oezguen; Holger Herlyn; James R Halpert; Leszek Wojnowski
Journal:  Drug Metab Dispos       Date:  2009-03-19       Impact factor: 3.922

7.  Identification and analysis of conserved sequence motifs in cytochrome P450 family 2. Functional and structural role of a motif 187RFDYKD192 in CYP2B enzymes.

Authors:  Numan Oezguen; Santosh Kumar; Aditya Hindupur; Werner Braun; B K Muralidhara; James R Halpert
Journal:  J Biol Chem       Date:  2008-05-21       Impact factor: 5.157

Review 8.  Engineering cytochrome P450 biocatalysts for biotechnology, medicine and bioremediation.

Authors:  Santosh Kumar
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-02       Impact factor: 4.481

9.  The effect of mutation of F87 on the properties of CYP102A1-CYP4C7 chimeras: altered regiospecificity and substrate selectivity.

Authors:  Chiung-Kuang J Chen; Tatiana Kh Shokhireva; Robert E Berry; Hongjun Zhang; F Ann Walker
Journal:  J Biol Inorg Chem       Date:  2008-04-08       Impact factor: 3.358

10.  Digging Deeper into CYP3A Testosterone Metabolism: Kinetic, Regioselectivity, and Stereoselectivity Differences between CYP3A4/5 and CYP3A7.

Authors:  Sylvie E Kandel; Lyrialle W Han; Qingcheng Mao; Jed N Lampe
Journal:  Drug Metab Dispos       Date:  2017-10-06       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.